Vice President (Technical)
Parexel
Ashtead, Surrey, England, United Kingdom
Cecil Nick, Vice President (Technical), at PAREXEL Consulting has been working in regulatory affairs and clinical development for over 30 years. He has particular expertise in orphan drugs, vaccines, anti-infectives, diabetes, monoclonals and biosimilars and has engaged in scores of interactions and meetings with regulatory agencies in the EU, US, Canada, Australia, Mexico and Brazil. He has also participated extensively in Industry and International meetings on clinical development and biosimilars.
Since joining PAREXEL in February 2001 Cecil has applied his extensive scientific, drug development and regulatory experience working with pharmacologists, statisticians and therapeutic experts in supporting clients with clinical development plans and regulatory strategies for EU, US and global approval.
Cecil is a Fellow of TOPRA and has been a guest lecture at Cardiff University MSc in Clinical Research and Greenwich University MSc in Pharmaceutical Sciences courses and Biotech Module leader for the TOPRA MSc course. He was on the editorial panel of SCRIP Clinical Research and has authored many articles on regulatory and clinical development issues.
Disclosure information not submitted.
Wednesday, May 14, 2025
10:45 - 11:45 CEST
Current Developments and Regulatory Trends in Clinical Trial Design
Thursday, May 15, 2025
12:00 - 13:00 CEST
The Value of Integrating Real-world and Trial Data to Increase Patient Benefit
Thursday, May 15, 2025
16:45 - 17:45 CEST